Prazitone
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
|
5-phenyl-5-(piperidin-2-ylmethyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
|
| Identifiers | |
| CAS Number | 2409-26-9 |
| ATC code | none |
| PubChem | CID 3050417 |
| ChemSpider | 2312482 |
| UNII | 6DZB018428 |
| Synonyms | 5-phenyl-5-(2-piperidylmethyl)barbituric acid |
| Chemical data | |
| Formula | C16H19N3O3 |
| Molar mass | 301.34 g/mol |
|
|
|
|
| |
Prazitone (AGN-511) is a barbiturate derivative developed in the 1970s.[1] Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant.[2] The dosage range in humans is around 200–600 mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.
References[edit]
|
|
|
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

